Top Markets
Coin of the day
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Rank in Stocks #27792
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Share Price
$2.52
Market Cap
$30.70M
Change (1 day)
7.85%
Change (1 year)
-59.28%
Country
KR
Trade Oncocross Co., Ltd. (382150)

Category

P/S ratio for Oncocross Co., Ltd. (382150)
P/S ratio as of 2026 TTM: 0
According to Oncocross Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Oncocross Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH